Dambkowski Carl bought APGE
October 1, 2025 · Form 4 insider transaction
Dambkowski Carl bought 2,385 shares of Apogee Therapeutics Inc at $22.86 per share, a transaction worth $54.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,385
Price
$22.86
Total value
$54.5K
InsiderDambkowski Carl
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 1, 2025
Filing dateOctober 3, 2025
Shares owned after289,843
OwnershipDirect
10b5-1 planNo
AmendedNo